ALBUTEIN (GRIFOLS USA, LLC)


Welcome to the PulseAid listing for the ALBUTEIN drug offered from GRIFOLS USA, LLC. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: GRIFOLS USA, LLC
NON-PROPRIETARY NAME: ALBUMIN (HUMAN)
SUBSTANCE NAME: ALBUMIN HUMAN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1978-08-15
END MARKETING DATE: 0000-00-00


ALBUTEIN PLASMA DERIVATIVE Details:

Item DescriptionALBUTEIN from GRIFOLS USA, LLC
LABELER NAME: GRIFOLS USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 12.5(g/250mL)
START MARKETING DATE: 1978-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68516-5214_a3dc8fb1-a0bf-fd09-875c-3f61804b2ec7
PRODUCT NDC: 68516-5214
APPLICATION NUMBER: BLA102478

Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxalta US Inc.Buminate
CSL Behring AGAlbuRx
GRIFOLS USA, LLCALBUTEIN
KEDRION BIOPHARMA, INC.Albuked